Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MIMEDX GROUP, INC.

(MDXG)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

MIMEDX GROUP, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)

09/13/2021 | 06:35am EDT

Item 7.01 Regulation FD.


On September 13, 2021, MIMEDX Group, Inc. (the "Company"), issued a press
release announcing the top-line results from two late-stage musculoskeletal
clinical trials of the Company's micronized dehydrated Human Amnion Chorion
Membrane (mdHACM): a Phase 2B clinical trial for the treatment of Knee
Osteoarthritis (KOA) and a Phase 3 clinical trial for the treatment of Plantar
Fasciitis (PF). A copy of the press release is attached hereto as Exhibit 99.1
and is incorporated herein for reference.

On September 13, 2021, Timothy R. Wright, MIMEDX Chief Executive Officer, Peter
M. Carlson, MIMEDX Chief Financial Officer, and Robert B. Stein, M.D. Ph.D,
MIMEDX Executive Vice President, Research and Development are expected to
present at the H.C. Wainwright 23rd Annual Global Investment Conference
beginning at 9:00 AM Eastern time. A copy of the presentation materials they
will use are attached hereto as Exhibit 99.2 and are incorporated herein for
reference. The presentation materials shall not be deemed "filed" for purposes
of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the
liabilities of that section and shall only be incorporated by reference into
another filing under the Exchange Act or Securities Act of 1933 if such
subsequent filing specifically references this Form 8-K.

--------------------------------------------------------------------------------

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.
Exhibit No.              Description of Exhibit
99.1                       Press Release     Sep    tember     1    3, 2021.
99.2                       Slide Presentation dated September 13, 2021.
104                      The cover page from this Current Report on Form

8-K, formatted in Inline XBRL.

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses

All news about MIMEDX GROUP, INC.
10/14MIMEDX : to Host Virtual Investor Day on December 7, 2021
AQ
10/13MIMEDX : Net Health Agreement with MIMEDX Streamlines Complex Insurance Benefits Verificat..
PR
10/13Net Health Announces Agreement with MiMedx Group, Inc
CI
09/14MIMEDX : HC Wainwright Adjusts Price Target for MiMedx Group to $8.50 From $20, Maintains ..
MT
09/13US Stocks Start Week Mostly Higher; Blue Chips Lead While Nasdaq Lags
MT
09/13Health Care Stocks Still Adding to Afternoon Slide
MT
09/13Top Midday Decliners
MT
09/13Health Care Stocks Slipping Monday Afternoon
MT
09/13MIMEDX : Amniotic Tissue Failed to Meet Primary Endpoints in Two Trials; Shares Plunge
MT
09/13Health Care Stocks Up Slightly in Premarket Monday Activity
MT
More news
Analyst Recommendations on MIMEDX GROUP, INC.
More recommendations